Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

It is an alkylating antitumor drug and is effective for multiple myeloma, breast cancer, ovarian cancer, chronic lymphocyte and granulocytic leukemia, malignant lymphoma and multiple myeloma. It has a good effect on the treatment of limb malignant tumors such as malignant melanoma, soft tissue sarcoma and osteosarcoma by arterial perfusion. The effect of racemes on testis seminoma is better. Preparations include tablets and injections.